Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

John Cox


  • Director at Repligen Corp (RGEN), 2019-05-17
  • Chief Executive Officer at Bioverativ Inc. (BIVV), 2018-03-08
  • Evp Pharmaceutical Oper & Tech at Biogen Inc. (BIIB), 2016-04-05
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BIIB $449.06 12,010 Officer 25,567 2015-03-25 Filing
BIIB $114.37 2,175 Officer 9,588 2011-11-01 Filing
BIIB $100.00 4,350 Officer 10,353 2011-04-21 Filing
BIIB $80.00 36,234 Officer 10,353 2011-04-13 Filing
BIIB $78.00 6,900 Officer 10,353 2011-04-11 Filing